New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 13, Issue 1, 2005, Pages 2-8

  Sasama, Jan ^a   Sherris, David A ^b   Shin, Seung Heon ^a   Kephart, Gail M ^a   Kern, Eugene B ^b   Ponikau, Jens U ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Allergic fungal sinusitis; Chronic rhinosinusitis; Chronic sinusitis; Eosinophils; Fungi; Inflammation

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; ITRACONAZOLE; MAJOR BASIC PROTEIN; MUCIN;

ALLERGIC FUNGAL SINUSITIS; ALTERNARIA; ASPERGILLUS; BRONCHOPULMONARY ASPERGILLOMA; CANDIDA; CLADOSPORIUM; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPEREOSINOPHILIA; IMMEDIATE TYPE HYPERSENSITIVITY; MYCOSIS; NOSE POLYP; PENICILLIUM; PRIORITY JOURNAL; REVIEW; RHINOSINUSITIS; SKIN TEST;

CHRONIC DISEASE; EOSINOPHILIA; HUMANS; MYCOSES; NASAL CAVITY; RHINITIS; SINUSITIS;

EID: 13244298250     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200502000-00003     Document Type: Review

References (57)

1. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003; 129(suppl):S1-S32.
2. Lethbridge-Cejku M, Schiller JS, Bernadel L: Summary health statistics for U.S. adults: National Health Interview Survey, 2002. National Center for Health Statistics. Vital Health Stat 2004; 10:222.
3. Bishai WR: Issues in the management of bacterial sinusitis. Otolaryngol Head Neck Surg 2002; 127:S3-S9.
4. Gliklich RE, Metson R: The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995; 113:104-109.
5. Bryson JM, Tasca RA, Rowe-Jones JM: Local and systemic eosinophilia in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis with and without polyposis. Clin Otolaryngol 2003; 28:55-58.
6. Bhattacharyya N: Chronic rhinosinusitis: is the nose really involved? Am J Rhinol 2001; 15:169-173.
7. Harlin SL, Ansel DG, Lane SR, et al. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988; 81:867-875. First study linking the eosinophilic inflammation to the disease of chronic rhinosinusitis.
8. Stoop AE, van der Heijden HA, Biewenga J, et al. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993; 91:616-622.
9. Hisamatsu K, Ganbo T, Nakazawa T, et al. Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro. J Allergy Clin Immunol 1990; 86:52-63.
10. Millar JW, Johnston A, Lamb D: Allergic aspergillosis of the maxillary sinuses. Proc Scottish Thorac Soc 1981; 36:710.
11. Katzenstein AL, Sale SR, Greenberger PA: Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72:89-93.
12. Robson JM, Hogan PG, Benn RA, et al. Allergic fungal sinusitis presenting as a paranasal sinus tumor. Aust N Z J Med 1989; 19:351-353.
13. Bent JP III, Kuhn FA: Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994; 111:580-588.
14. deShazo RD, Swain RE: Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995; 96:24-35.
15. Zinreich SJ, Kennedy DW, Malat J, et al. Fungal sinusitis: diagnosis with CT and MR imaging. Radiology 1988; 169:439-444.
16. Cody DT II, Neel HB III, Ferreiro JA, et al. Allergic fungal sinusitis: the Mayo Clinic experience. Laryngoscope 1994; 104:1074-1079.
17. Morpeth JF, Rupp NT, Dolen WK, et al. Fungal sinusitis: an update. Ann Allergy Clin Immunol 1996; 76:128-139.
18. Granville L, Chirala M, Cernoch P, et al. Fungal sinusitis: histologic spectrum and correlation with culture. Hum Pathol 2004; 35:474-481.
19. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74:877-884.
20. Braun H, Buzina W, Freudenschuss K, et al. Eosinophilic fungal rhinosinusitis: a common disorder in Europe? Laryngoscope 2003; 113:264-269. This study demonstrates fungi in the nasal and paranasal cavities by histology in 75.5% (28/37) of consecutive surgical chronic rhinosinusitis patients and after culture in 91.3% (84/92) in a European population. The investigators could also show the widespread presence of fungi in specimens from healthy controls using more sensitive techniques. These results suggest that fungi can be ubiquitously found in the nasal and paranasal cavities of nearly all humans with or without chronic rhinosinusitis.
21. Buzina W, Braun H, Schimpl K, et al. Bipolaris spicifera causes fungus balls of the sinuses and triggers polypoid chronic rhinosinusitis in an immunocompetent patient. J Ciin Microbiol 2003; 41:4885-4887.
22. Taylor MJ, Ponikau JU, Sherris DA, et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002; 127:377-383.
23. Collins M, Nair S, Smith W, et al. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope 2004; 114:1242-1246.
24. Weschta M, Rimek D, Formanek M, et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004; 113:1122-1128.
25. Lackner A, Freudenschuss K, Buzina W, et al. From when on can fungi be identified in nasal mucus of humans? [in German]. Laryngorhinootologie 2004; 83:117-121. This study demonstrates the early colonization of the nasal and paranasal cavities of newborns within the first days of life and supplies data suggesting the ubiquitous existence of fungi in the sinuses of essentially all humans.
26. Taj-Aldeen SJ, Hilal AA, Schell WA: Allergic fungal rhinosinusitis: a report of 8 cases. Am J Otolaryngol 2004; 25:213-218.
27. Castelnuovo P, De Bernardi F, Cavanna C, et al. Invasive fungal sinusitis due to Bipolaris hawaiiensis. Mycoses 2004; 47:76-81.
28. Uri N, Cohen-Kerem R, Elmalah I, et al. Classification of fungal sinusitis in immunocompetent patients. Otolaryngol Head Neck Surg 2003; 129:372-378.
29. Cameli-Rojas V, Mata-Essayag S, de Capriles CH, et al. Aspergillus species in patients with chronic rhinosinusitis. Mycoses 2004; 47:47-49.
30. Gosepath J, Brieger J, Vlachtsis K, et al. Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis. Am J Rhinol 2004; 18:9-13. This study demonstrates the existence of fungal DNA in polypoid nasal tissues of 100% (27/27) patients with chronic rhinosinusitis and in 66.6% (10/15) of the nasal mucosa derived from healthy controls using highly sensitive PCR techniques. Furthermore, PCR screening specifically for Alternaria tested positive in 100% of the chronic rhinosinusitis patients, whereas none of the healthy control samples tested positive for Alternaria DNA. These data provide the previously lacking proof of the existence of fungal antigens possibly reaching the cytokine producing T lymphocytes in the polypoid tissue from chronic rhinosinusitis patients. These findings could link mechanisms driving the eosinophilic inflammation typically found in the polypoid nasal tissue of chronic rhinosinusitis patients to the existence of fungi in the nasal and paranasal cavities.
31. Shin S-H, Ponikau JU, Sherris DA, et al. Rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004; 114: 1369-1375. This study demonstrates that approximately 90% and 100% of PBMCs derived from patients with chronic rhinosinusitis produced high levels of interleukin-5 and interleukin-13, respectively, but not PBMCs from healthy controls, on stimulation with Alternaria antigens. Furthermore, the levels of interferon-γ released by the PBMCs from chronic rhinosinusitis patients are significantly higher than the levels of interferon-γ produced by PBMCs from normal controls after stimulation with Alternaria. These reactions seem to be specific for the fungal species of Alternaria. Furthermore, this study demonstrates higher levels of serum IgG antibodies to Alternaria and Cladosporium in patients with chronic rhinosinusitis compared with healthy controls, indicating an increased immunologic exposure of the chronic rhinosinusitis patient's immune system to these fungi. Only 28% of these chronic rhinosinusitis patients had elevated specific IgE for Alternaria, and no correlation existed between specific IgE for Alternaria and the intensity of the interleukin-5 responses, which strongly questions the relation of IgE and the eosinophilic inflammation found in chronic rhinosinusitis patients.
32. Ferguson BJ: Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope 2000; 110:799-813.
33. Kupferberg SB, Bent JP 3rd, Kuhn FA: Prognosis for allergic fungal sinusitis. Otolaryngol Head Neck Surg 1997; 117:35-41.
34. Puchelle E, Bajolet O, Abely M: Airway mucus in cystic fibrosis. Paediatr Respir Rev 2002; 3:115-119.
35. Zahm JM, Galabert C, Chaffin A, et al. Improvement of cystic fibrosis airway mucus transportability by recombinant human DNase is related to changes in phospholipid profile. Am J Respir Crit Care Med 1998; 157: 1779-1784.
36. Mabry RL, Manning S: Radioallergosorbent microscreen and total immunoglobulin E in allergic fungal sinusitis. Otolaryngol Head Neck Surg 1995; 113:721-723.
37. Feger TA, Rupp NT, Kuhn FA, et al. Local and systemic eosinophil activation in allergic fungal sinusitis. Ann Allergy Asthma Immunol 1997; 79:221-225.
38. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol 2003; 112:877-882. This article describes the heterogeneity of the eosinophilic inflammation found in the polypoid sinus tissue of chronic rhinosinusitis patients. Furthermore, interesting histologic similarities between chronic rhinosinusitis and asthma are presented, suggesting a common pathogenesis for both chronic rhinosinusitis and asthma.
39. Hamelmann E, Schleimer RP: Corticosteroid treatment in bronchial asthma: for better or for worse? J Allergy Clin Immunol 2003; 111:248-250.
40. Hamilos DL, Leung DY, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995; 96:537-544.
41. Hamilos DL, Leung DY, Wood R, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 1996; 15:443-450.
42. al Ghamdi K, Ghaffar O, Small P, et al. IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol 1997; 26:160-166.
43. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390-2394.
44. Lopez AF, Sanderson CJ, Gamble JR, et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988; 167:219-224.
45. Simon HU, Yousefi S, Schranz C, et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997; 158:3902-3908.
46. Hamilos DL, Leung DY, Huston DP, et al. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy 1998; 28:1145-1152. This article analyzes the cytokine immunoreactivity for interleukin-5, GM-CSF, and RANTES mRNA in allergic and nonallergic nasal polyps from patients with chronic rhinosinusitis using in situ hybridization. The authors demonstrate that GM-CSF, interleukin-5, and RANTES are produced in increased amounts in the polypoid sinus tissue of chronic rhinosinusitis patients compared with healthy controls independently of the patients' allergy status. The authors hypothesize that mechanisms independent from allergic reactions might be responsible for eosinophil accumulation and activation in allergic vs nonallergic chronic rhinosinusitis patients.
47. Hamilos DL: Chronic sinusitis. J Allergy Clin Immunol 2000; 106:213-227.
48. Oliveira SH, Fonseca SG, Romao PR, et al. Microbicidal activity of eosinophils is associated with activation of the arginine-NO pathway. Parasite Immunol 1998; 20:405-412.
49. Miller CH, Pudiak DR, Hatem F, et al. Accumulation of interferon gamma-producing TH1 helper T cells in nasal polyps. Otolaryngol Head Neck Surg 1994; 111:51-58.
50. Sanchez-Segura A, Brieva JA, Rodriguez C: T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol 1998; 102:953-960.
51. Inoue Y, Shin SH, Ponikau JU, et al. The fungus, Alternaria, induces activation and degranulation of human eosinophils [abstract]. J Allergy Clin Immunol 2000; 109(suppl):S165.
52. Rains BM 3rd, Mineck CW: Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003; 17:1-8.
53. Marple B, Newcomer M, Schwade N, et al. Natural history of allergic fungal rhinosinusitis: a 4- to 10-year follow-up. Otolaryngol Head Neck Surg 2002; 127:361-366.
54. Ponikau JU, Sherris DA, Kita H, et al. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002; 110:862-866.
55. Ricchetti A, Landis BN, Maffioli A, et al. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002; 116:261-263.
56. Miller TR, Muntz HR, Gilbert ME, et al. Comparison of topical medication delivery systems after sinus surgery. Laryngoscope 2004; 114:201-204. In this article, different delivery vehicles for medications into the sinus cavities of patients with chronic rhinosinusitis are investigated. The authors demonstrate that a spray is a vastly inferior delivery vehicle for medications into the sinuses compared with a bulb syringe, even in patients without recurrent nasal polyps after sinus surgery and with open sinus ostia.
57. Ponikau JU, Sherris DA, Weaver A, et al. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blinded pilot trial. J Allergy Clin Immunol 2005; in press. This is the first double-blind, placebo-controlled trial of consecutive and unselected patients with chronic rhinosinusitis using a bulb syringe as a delivery vehicle. This study demonstrates a reduced inflammatory mucosal thickening on CT scan and nasal endoscopy and decreased levels of intranasal cytokines and markers for eosinophilic inflammation in chronic rhinosinusitis patients compared with placebo after 6 months. These results suggest a beneficial effect of topical antifungal treatment of patients with chronic rhinosinusitis when appropriate delivery methods of the medication and a sufficient duration of the treatment are considered.